How tumor-derived GABA disables tumor TLSs and drives anti-PD-1 resistance in cancer
Can a single gut bacterium rescue failing immunotherapy? F. prausnitzii strain EXL01 restores checkpoint-inhibitor response
How mature TLSs identify solid tumor patients more likely to benefit from PD-1 blockade
